Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Kneat.com Inc KSIOF


Primary Symbol: T.KSI

Healthcare Medical Devices
kneat.com, inc. develops and markets the Kneat Gx software-as-a-service (SaaS) platform. It designs, develops and supplies software for data and document management within regulated environments. The Company’s focus is to service the facilities, equipment and computer systems (CSV) validation market initially within the global life sciences industry. The Company’s product is Kneat Gx, a configurable, off-the-shelf application focused on validation lifecycle management and testing primarily within the life sciences industry. Kneat Gx provides a compliant digital solution that enables companies in the life sciences industry to become efficient and compliant with an automated process that has traditionally been manual, inefficient and paper-based. Its various validation processes include electronic logbook management, analytical instrument validation, utility and facility validation, process validation, method validation and equipment validation, cold chain validation, and others.


TSX:KSI - Post by User

Kneat.com Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1570)
•••
Post by Possibleidiot01on Jan 05, 2024 8:52pm
96 Views
Post# 35813425

Polypharma Biologics - new customer

Polypharma Biologics - new customerThis appears to be new - their Linkedin posts aren't always consecutive , most recent to older.

Kneat Solutions
 
 
New Customer Announcement

Polpharma Biologics, an international biotechnology company with integrated operations in the European Union, that develops and manufactures biosimilars, has chosen Kneat to digitalize its Computer System Validation process.

Why Kneat Gx?

Most innovative and efficient solution on the market

Best product fit

First class support from Kneat team

If you’re thinking about digitalizing your validation processes in 2024, the Digital Validation Handbook helps you to understand which direction to take. Download your copy today!

https://hubs.li/Q02f4vwN0

#NewCustomer #KneatGx #DigitalTransformation #CSV #SpeedToMarket




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities